The global financial landscape in the first week of February 2026 was defined by a profound and systemic recalibration of risk, characterised by a transition from liquidity-driven expansion to a regime of rigid valuation discipline. Within this broader market turbulence, the healthcare technology and digital health sectors experienced heightened volatility, acting as a microcosm of the tension between long-term innovation and short-term capital constraints. While the sell-off